Dalvance Approval Is Durata’s GAIN: First Test Of FDA’s Antibiotics Incentives
This article was originally published in The Pink Sheet Daily
Executive Summary
Durata has honor of having first drug approved under Qualified Infectious Disease Product designation and gains the benefits of an added five years of market exclusivity.